Compare ANAB & QCRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANAB | QCRH |
|---|---|---|
| Founded | 2005 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | 2015 | 1996 |
| Metric | ANAB | QCRH |
|---|---|---|
| Price | $62.39 | $96.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | $71.67 | ★ $98.25 |
| AVG Volume (30 Days) | ★ 570.6K | 124.5K |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | ★ 91.02 | 11.62 |
| EPS | N/A | ★ 1.99 |
| Revenue | ★ $234,603,000.00 | $165,999,610.00 |
| Revenue This Year | N/A | $8.46 |
| Revenue Next Year | $52.14 | $5.59 |
| P/E Ratio | ★ N/A | $48.57 |
| Revenue Growth | ★ 157.01 | 20.72 |
| 52 Week Low | $17.11 | $66.71 |
| 52 Week High | $73.30 | $99.87 |
| Indicator | ANAB | QCRH |
|---|---|---|
| Relative Strength Index (RSI) | 56.57 | 58.10 |
| Support Level | $52.32 | $86.16 |
| Resistance Level | $67.69 | $97.25 |
| Average True Range (ATR) | 3.27 | 2.64 |
| MACD | 0.87 | 0.00 |
| Stochastic Oscillator | 54.78 | 58.59 |
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely Quad City Bank & Trust (QCBT), Cedar Rapids Bank & Trust (CRBT), Community State Bank (CSB) and Guaranty Bank (GB). It generates revenue in the form of interest.